Medicine & Life Sciences
Neoplasms
100%
Prostatic Neoplasms
93%
Palliative Care
59%
Breast Neoplasms
50%
Radiotherapy
50%
Quality of Life
46%
Cancer Survivors
45%
Rheumatoid Arthritis
45%
Therapeutics
36%
Pain
33%
Arachidonate 15-Lipoxygenase
31%
Systematic Reviews
30%
Randomized Controlled Trials
29%
Fatigue
29%
Survival
29%
Lipoxygenase
28%
Exercise
27%
Radiation
27%
Decision Support Techniques
26%
Confidence Intervals
26%
Drug Therapy
23%
Health
23%
Early Detection of Cancer
22%
Prostatectomy
22%
Androgens
22%
Cost-Benefit Analysis
22%
Costs and Cost Analysis
20%
Hispanic Americans
20%
Rheumatology
19%
Symptom Assessment
19%
Odds Ratio
18%
Physicians
18%
Breast
18%
Brachytherapy
18%
Knee Osteoarthritis
18%
Depression
18%
Prostate
17%
Ovarian Neoplasms
16%
oleandrin
16%
Decision Making
16%
Population
15%
Cohort Studies
15%
Survivors
15%
Primary Health Care
14%
Ambulatory Care
14%
Referral and Consultation
14%
Carcinogenesis
14%
Acupuncture
14%
Communication
13%
Dinoprostone
13%
Delirium
13%
Colorectal Neoplasms
13%
Mortality
13%
Endometrial Neoplasms
13%
Prostate-Specific Antigen
13%
Education
12%
Cyclooxygenase 2
12%
Knee Replacement Arthroplasties
12%
Health Care Outcome Assessment
12%
Opioid Analgesics
12%
Placebos
12%
Clinical Trials
12%
Papanicolaou Test
12%
Uterine Cervical Neoplasms
11%
Peroxisome Proliferator-Activated Receptors
11%
Sleep
11%
Lung Neoplasms
11%
Osteoarthritis
11%
Anxiety
11%
Complementary Therapies
11%
Watchful Waiting
11%
Meta-Analysis
11%
Chemoprevention
11%
Radiation Oncology
11%
Comorbidity
10%
Guidelines
10%
Patient Preference
10%
Renal Cell Carcinoma
10%
Cancer Pain
10%
African Americans
10%
Antirheumatic Agents
10%
prostaglandin E3
10%
Spirituality
10%
Mastectomy
9%
PBI-05204
9%
Self Efficacy
9%
Methotrexate
9%
Caregivers
9%
Social Support
9%
Arthritis
9%
Patient Reported Outcome Measures
9%
European Continental Ancestry Group
9%
Databases
9%
HIV
9%
Systemic Scleroderma
9%
Yoga
9%
Nerium
9%
Prospective Studies
9%
Recurrence
9%
Pancreatic Neoplasms
9%